Prof. Dr. Burçak YILMAZ

Nuclear Medicine Oncology Center

Medical Interests

Radionuclide Therapies
PET-CT and PET-MRI Imaging & Reporting
Conventional Nuclear Medicine Imaging & Reporting (SPECT/CT, Gamma Camera)

Education

2018–Present – University of Health Sciences – PhD (Molecular Oncology)
2012 – Istanbul University-Cerrahpaşa – PhD (Nuclear Medicine)
2006 – Istanbul University-Cerrahpaşa – Master’s Degree (English Medicine Program)
2000 – Bahçeşehir College – Valedictorian (First Rank Graduation)

Experience

2025–Present – Biruni University Faculty of Medicine Hospital – Associate Professor (Nuclear Medicine)
2023–2024 – Oregon Health and Science University, Department of Nuclear Medicine – Postdoctoral Scholar
2022–2023 – Medipol University Bahçelievler Hospital – Associate Professor (Nuclear Medicine)
2020–2022 – University of Health Sciences Başakşehir Çam and Sakura City Hospital, Nuclear Medicine Clinic – Associate Professor (Training and Administrative Supervisor)
2020 – University of Health Sciences Istanbul Training and Research Hospital – Associate Professor (Nuclear Medicine)
2017 – University of Washington, Department of Nuclear Medicine – Observer Physician
2012–2020 – Training and Research Hospitals affiliated with the University of Health Sciences (Istanbul) – Specialist Physician (Nuclear Medicine)
2007–2012 – Istanbul University-Cerrahpaşa, Department of Nuclear Medicine – Resident Physician

Languages

English
German

Certificate of Merit award, 2017; Sarcoidosis F-18 FDG PET/CT Imaging and Atypical Presentations; The Radiological Society of North America (RSNA), UNITED STATES.
Prof. Dr. Suphi Artunkal Award Candidate Paper, 2019; PSMA targeted nuclear robotic surgery: preliminary results; 31st National Nuclear Medicine Congress.
Prof. Dr. Suphi Artunkal Award Candidate Paper, 2021; Evaluation of interim chemotherapy response with Ga-68 FAPI-46 PET/CT: Preliminary results; 33rd National Nuclear Medicine Congress, TURKEY.
Prof. Dr. Suphi Artunkal Award Candidate Paper, 2021; Diagnostic success of Ga-68 FAPI-04 PET/CT and F-18 FDG PET/CT in different cancer types; 33. National Nuclear Medicine Congress; TURKEY.
Best Resident Abstract, Western Regional Chapter of Society of Nuclear Medicine and Molecular Imaging, November 2023; Prediction of Parkinson's Disease rapid progression with machine learning and I-123 Ioflupane SPECT follow up; Vancouver, CANADA.
Scientific Research Project- University of Health Sciences (2018): The contribution of Tc-99m PSMA SPECT/CT imaging to staging and restaging in patients with prostate cancer, TURKEY.
Scientific Research Project- University of Health Sciences (2020): Neoadjuvant chemotherapy response evaluation with Ga-68 FAPI PET/CT, TURKEY.
Yilmaz B, et al. (2019). Effect of external cooling on Lu-177 PSMA uptake for parotid glands. Journal of Nuclear Medicine, 60(10), 1388- 1393. Doi: 10.2967/jnumed.119.226449

Online Appointment

We are one click away with our online appointment system to facilitate your access to our health services.

Call Centre

You can call +90 444 8 276 to contact our experienced patient representatives who are available 24/7.

Treatments

Discover a comprehensive range of advanced treatments tailored to meet diverse healthcare needs.

Technology

Our hospital is equipped with state-of-the-art medical devices, innovative diagnostic tools, and precision treatment systems to deliver exceptional care.